Aclarion’s Nociscan shows up to 87% agreement with discography in lumbar disc pain study

• Aclarion announced publication of an independent, peer-reviewed Nociscan study in the European Spine Journal, providing real-world evidence for its noninvasive diagnostic platform.
• The London Spine Clinic study of 20 patients across 55 lumbar discs found Nociscan broadly agreed with invasive discography in identifying painful discs.
• At the study site, a three-disc Nociscan exam cost approximately £2,040, versus roughly £2,775 for an equivalent discogram.
• Nociscan patients avoided pain-related recovery time, including two missed workdays often associated with discography.
• Researchers cited the small sample; larger, multicenter studies are being organized to assess Nociscan’s potential to replace discography in selected patients.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aclarion Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610220700PRIMZONEFULLFEED9851103) on October 22, 2026, and is solely responsible for the information contained therein.